Swedbank Trimmed Costco Wholesale (COST) Stake; Repligen (RGEN) Has 1.69 Sentiment

Repligen Corporation (NASDAQ:RGEN) Logo

Swedbank decreased Costco Wholesale (COST) stake by 30.48% reported in 2018Q4 SEC filing. Swedbank sold 316,812 shares as Costco Wholesale (COST)’s stock declined 5.18%. The Swedbank holds 722,462 shares with $145.97M value, down from 1.04 million last quarter. Costco Wholesale now has $103.11 billion valuation. The stock increased 0.21% or $0.5 during the last trading session, reaching $234.34. About 1.18 million shares traded. Costco Wholesale Corporation (NASDAQ:COST) has risen 15.54% since March 15, 2018 and is uptrending. It has outperformed by 11.17% the S&P500. Some Historical COST News: 07/03/2018 – COSTCO SAYS U.S. MEMBERSHIP RENEWAL RATE RISES TO 90.1% IN 2Q; 07/03/2018 – COSTCO WHOLESALE CORP COST.O – SECOND QUARTER TRAFFIC OR SHOPPING FREQUENCY WAS UP 3.7% WORLDWIDE AND 3.4% IN THE U.S. – CONF CALL; 24/04/2018 – Costco Wholesale Corporation Announces an Increase in Its Quarterly Cash Dividend; 24/04/2018 – COSTCO WHOLESALE BOOSTS QTR DIV/SHR TO 57C FROM 50C, EST. 55C; 07/03/2018 – COSTCO BEGINS ANALYST CALL; 19/04/2018 – National Business Group on Health Recognizes Costco Wholesale Corporation with 2018 Helen Darling Award for Excellence in Health Care Value and Innovation; 07/03/2018 – Costco 2Q EPS $1.59; 09/05/2018 – COSTCO WHOLESALE CORP COST.O SAYS NET SALES OF $10.81 BLN FOR RETAIL MONTH OF APRIL, FOUR WEEKS ENDED MAY 6, 2018, AN INCREASE OF 13.1 PERCENT; 16/05/2018 – As Skin-Baring Season Dawns, SeroVital’s hGH Booster Becomes Easier to Find Through National Costco Distribution; 09/05/2018 – Costco Wholesale Corporation Reports April Sales Results

Repligen Corp (RGEN) investors sentiment increased to 1.69 in Q4 2018. It’s up 0.56, from 1.13 in 2018Q3. The ratio improved, as 122 funds opened new or increased positions, while 72 sold and reduced their positions in Repligen Corp. The funds in our database now own: 39.90 million shares, up from 39.62 million shares in 2018Q3. Also, the number of funds holding Repligen Corp in top ten positions was flat from 2 to 2 for the same number . Sold All: 11 Reduced: 61 Increased: 72 New Position: 50.

Investors sentiment decreased to 1.04 in 2018 Q4. Its down 0.07, from 1.11 in 2018Q3. It worsened, as 70 investors sold COST shares while 431 reduced holdings. 121 funds opened positions while 400 raised stakes. 336.90 million shares or 12.99% more from 298.17 million shares in 2018Q3 were reported. Chilton Invest Limited Liability Corporation has 432,252 shares. Washington Trust reported 37,967 shares stake. Gotham Asset Mngmt Limited Com accumulated 5,674 shares. Arrowgrass Capital Prtnrs (Us) Ltd Partnership has 74,085 shares. Adirondack has 0.24% invested in Costco Wholesale Corporation (NASDAQ:COST). Peregrine Asset Advisers Inc holds 2.17% of its portfolio in Costco Wholesale Corporation (NASDAQ:COST) for 8,152 shares. 2,477 were accumulated by Lombard Odier Asset (Switzerland) Sa. Motley Fool Asset Mngmt Ltd Limited Liability Company has invested 1.3% of its portfolio in Costco Wholesale Corporation (NASDAQ:COST). Nuveen Asset Ltd Limited Liability Company owns 11,388 shares. King Luther Capital Mngmt Corp stated it has 9,449 shares or 0.02% of all its holdings. Leuthold Group Limited Liability Corp invested 1.36% in Costco Wholesale Corporation (NASDAQ:COST). 16,855 were accumulated by Vident Investment Advisory Ltd Liability Corp. Convergence Invest Prtnrs Ltd Llc has invested 0.07% in Costco Wholesale Corporation (NASDAQ:COST). Cullinan Associate Incorporated accumulated 0.02% or 1,170 shares. Freestone Lc holds 0.28% of its portfolio in Costco Wholesale Corporation (NASDAQ:COST) for 20,499 shares.

Swedbank increased F5 Networks Inc (NASDAQ:FFIV) stake by 145,037 shares to 798,210 valued at $128.22 million in 2018Q4. It also upped Celgene Corp (NASDAQ:CELG) stake by 66,517 shares and now owns 2.39 million shares. Target Corp (NYSE:TGT) was raised too.

More notable recent Costco Wholesale Corporation (NASDAQ:COST) news were published by: Nasdaq.com which released: “It Was a Costco Christmas Last Year – Nasdaq” on March 15, 2019, also Nasdaq.com with their article: “3 Reasons Why Growth Investors Shouldn’t Overlook Costco (COST) – Nasdaq” published on March 14, 2019, Nasdaq.com published: “DG vs. COST: Which Stock Should Value Investors Buy Now? – Nasdaq” on February 20, 2019. More interesting news about Costco Wholesale Corporation (NASDAQ:COST) were released by: Nasdaq.com and their article: “Costco (COST) Looks Good: Stock Adds 5.1% in Session – Nasdaq” published on March 11, 2019 as well as Nasdaq.com‘s news article titled: “Costco (COST) Q2 Earnings Preview – Nasdaq” with publication date: March 06, 2019.

Among 12 analysts covering Costco Wholesale (NASDAQ:COST), 9 have Buy rating, 0 Sell and 3 Hold. Therefore 75% are positive. Costco Wholesale had 19 analyst reports since September 17, 2018 according to SRatingsIntel. The rating was maintained by Gordon Haskett Capital Corporation with “Buy” on Friday, March 8. Citigroup maintained it with “Buy” rating and $257 target in Friday, October 5 report. BMO Capital Markets maintained the shares of COST in report on Friday, October 5 with “Outperform” rating. The stock of Costco Wholesale Corporation (NASDAQ:COST) has “Buy” rating given on Friday, March 8 by UBS. The rating was downgraded by Citigroup to “Neutral” on Monday, December 3. The stock has “Buy” rating by Bank of America on Friday, March 8. Deutsche Bank maintained Costco Wholesale Corporation (NASDAQ:COST) on Friday, March 8 with “Hold” rating. J.P. Morgan maintained it with “Buy” rating and $248 target in Friday, March 8 report. The stock of Costco Wholesale Corporation (NASDAQ:COST) earned “Equal-Weight” rating by Barclays Capital on Monday, September 17. JP Morgan maintained Costco Wholesale Corporation (NASDAQ:COST) on Monday, September 17 with “Overweight” rating.

Since October 1, 2018, it had 0 insider purchases, and 8 selling transactions for $14.33 million activity. DECKER SUSAN L had sold 1,611 shares worth $332,108. LAZARUS FRANZ E also sold $5.22 million worth of Costco Wholesale Corporation (NASDAQ:COST) on Thursday, October 25. Shares for $945,940 were sold by GALANTI RICHARD A. Shares for $458,976 were sold by LIBENSON RICHARD M. 22,500 shares were sold by JELINEK W CRAIG, worth $5.03M on Monday, October 29. $1.49 million worth of Costco Wholesale Corporation (NASDAQ:COST) was sold by Vachris Roland Michael on Monday, October 15. $707,430 worth of stock was sold by MEISENBACH JOHN W on Monday, October 1.

The stock increased 0.88% or $0.52 during the last trading session, reaching $59.69. About 116,413 shares traded. Repligen Corporation (RGEN) has risen 74.61% since March 15, 2018 and is uptrending. It has outperformed by 70.24% the S&P500. Some Historical RGEN News: 17/05/2018 – Repligen to Participate in 15th Annual Craig-Hallum Institutional Investor Conference; 08/05/2018 – Repligen 1Q EPS 8c; 08/05/2018 – REPLIGEN CORP RGEN.O SEES FY 2018 REVENUE $182 MLN TO $188 MLN; 02/05/2018 – Wells Capital Management Inc. Exits Position in Repligen; 08/05/2018 – REPLIGEN FY REV. GUIDANCE RAISED TO $182-$188M, EST. $183.6M; 17/05/2018 – Dir Ryan Jr Gifts 900 Of Repligen Corp; 08/05/2018 – REPLIGEN CORP RGEN.O SEES FY 2018 GAAP SHR $0.32 TO $0.36; 28/03/2018 Repligen Closes Above 50-Day Moving Average: Technicals; 08/05/2018 – Repligen Raises FY18 View To EPS 32c-EPS 36c; 17/05/2018 – Repligen Forms Golden Cross: Technicals

Analysts await Repligen Corporation (NASDAQ:RGEN) to report earnings on May, 14. They expect $0.19 EPS, up 11.76% or $0.02 from last year’s $0.17 per share. RGEN’s profit will be $8.35 million for 78.54 P/E if the $0.19 EPS becomes a reality. After $0.21 actual EPS reported by Repligen Corporation for the previous quarter, Wall Street now forecasts -9.52% negative EPS growth.

Repligen Corporation, a bioprocessing company, focuses on the development, production, and commercialization of products used in the production of antibody therapeutics, recombinant proteins, and vaccines worldwide. The company has market cap of $2.62 billion. It makes various forms of Protein A, a critical component used to purify antibody drugs. It has a 161.32 P/E ratio. The firm also supplies alternating tangential flow system filtration devices and protein cell culture supplements that are used in clinical and commercial stage manufacturing to enhance biologic drug yields.

Since January 1, 0001, it had 0 insider buys, and 3 sales for $2.15 million activity.

Repligen Corporation (NASDAQ:RGEN) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.